米国企業
Elevance Health, Inc.

Elevance Health, Inc.ELV

時価総額

$1251.8億

PER

	2010年 12月31日	2011年 12月31日	2013年 12月31日	2014年 12月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日
Net Income	-	-	-	-	-	-	-	-	-	-	6,095	6,019
Net losses (gains) on financial instruments	-	-	-	-	-	-	-	-	-	-	318	-550
Equity in net earnings of other invested assets	-	-	-	-	-	-	-	-	-	-	562	293
Depreciation and amortization	-	-	-	-	-	-	-	-	-	1,154	1,302	1,675
Deferred income taxes	102	74	59	31	-66	127	-1,272	91	81	-540	326	-76
Impairment of property and equipment	95	-	48	8	2	45	3	5	-	198	73	7
Share-based compensation	136	135	146	169	148	165	170	226	294	283	255	264
Receivables, net	-110	402	418	1,900	43	1,381	22	695	1,053	256	2,138	2,510
Other invested assets	5	9	15	22	-6	19	36	1	48	32	70	-11
Other assets	320	259	34	-405	-34	128	629	26	170	283	-37	-120
Policy liabilities	-331	978	-346	1,241	193	322	732	-1,059	1,826	3,528	2,597	2,254
Unearned income	-	-	-	-	-	-	-	-	-	202	-113	-42
Accounts payable and other liabilities	-	-	-	-	-	-	-	-	-	1,978	719	824
Income taxes	-	-	-	-	-	179	-194	323	-325	72	140	-338
Other, net	44	14	39	84	5	97	165	205	92	6	-21	66
Net cash provided by operating activities	1,417	3,374	3,052	3,369	4,116	3,205	4,185	3,827	6,061	10,688	8,364	8,399
Purchases of investments	-	-	-	-	-	-	-	-	-	19,492	18,669	24,946
Proceeds from sale of investments	-	-	-	-	-	-	-	-	-	11,318	10,269	11,988
Maturities, calls and redemptions from investments	3,322	1,891	1,837	1,319	1,314	1,419	1,848	1,938	2,437	4,741	4,344	10,620
Changes in securities lending collateral	-	-29	405	546	-214	-222	-624	149	-254	849	956	301
Purchases of subsidiaries, net of cash acquired	-0	600	-	-	639	-	2,080	1,760	-	1,976	3,476	649
Purchases of property and equipment	451	520	647	715	638	584	800	1,208	1,077	1,021	1,087	1,152
Other, net	76	31	-1	0	8	3	-12	71	50	45	63	120
Net cash used in investing activities	-1,271	-942	-2,234	-975	-1,151	-514	-5,082	-1,259	-2,792	-7,324	-9,638	-4,560
Proceeds from (Repayments of) Commercial Paper	-	464	-192	-379	682	-53	175	-107	-297	-150	50	-300
Proceeds from long-term borrowings	1,089	1,097	1,250	2,700	1,227	-	5,458	835	2,473	2,484	3,462	3,071
Repayments of long-term borrowings	482	705	1,802	1,730	2,697	-	2,815	1,684	1,123	1,932	1,068	1,899
Proceeds from Short-Term Debt	-	100	1,100	2,050	2,760	2,400	5,835	9,120	7,590	970	1,325	1,365
Repayments of short-term borrowings	-	100	950	2,050	2,620	2,500	5,000	9,250	8,035	1,670	1,050	1,375
Changes in securities lending payable	-	-29	405	546	-214	-222	-624	150	-254	849	956	302
Changes in bank overdrafts	-28	264	10	173	-244	514	71	-210	-169	-	-	933
Repurchase and retirement of common stock	4,360	3,040	1,620	2,999	1,516	-	1,998	1,685	1,701	2,700	1,900	2,316
Cash dividends	-	358	448	481	657	684	705	776	818	954	1,104	1,229
Proceeds from Stock Options Exercised	144	245	525	301	186	119	225	173	187	176	203	182
Taxes paid through withholding of common stock under employee stock plans	-	-	-	-	-	-	47	81	84	128	102	93
Other, net	-	-	-	-	-	-	-	-	-	488	-349	41
Net cash (used in) provided by financing activities	-3,169	-2,019	-1,718	-1,822	-2,997	-733	427	-2,241	-2,266	-2,567	423	-1,318
Effect of foreign exchange rates on cash and cash equivalents	-	-	-	-	-	-	-	-	-	-	-	-14
Change in cash and cash equivalents	-	-	-	-	-	-	-	-	-	804	-861	2,507